Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Experimental Neurology

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2016.06.017PMID 27317990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb

  2016cited by this paper
• Dynamics of IL-4 and IL-13 expression in the airways of sheep following allergen challenge

  2015cited by this paper
• Murine model: maternal administration of stem cells for prevention of prematurity.

  2015cited by this paper
• Human Umbilical Cord Blood Cells Ameliorate Motor Deficits in Rabbits in a Cerebral Palsy Model

  2015cited by this paper
• Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction

  2014cited by this paper
• Monocytes are essential for the neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat.

  2014cited by this paper
• Could Cord Blood Cell Therapy Reduce Preterm Brain Injury?

  2014cited by this paper
• Microglia toxicity in preterm brain injury

  2014cited by this paper
• Predictors of neurological outcome in cooled neonates

  2013cited by this paper
• Timing of Umbilical Cord Blood Derived Mesenchymal Stem Cells Transplantation Determines Therapeutic Efficacy in the Neonatal Hyperoxic Lung Injury

  2013cited by this paper
• Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells

  2013cited by this paper
• Human Amnion Epithelial Cells Reduce Fetal Brain Injury in Response to Intrauterine Inflammation

  2013cited by this paper
• Cell therapy for neonatal hypoxia–ischemia and cerebral palsy

  2012cited by this paper
• Determination of the Therapeutic Time Window for Human Umbilical Cord Blood Mononuclear Cell Transplantation following Experimental Stroke in Rats

  2012cited by this paper
• Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury.

  2012cited by this paper
• Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants

  2012cited by this paper
• The Yin and Yang of Microglia

  2011cited by this paper
• Human Umbilical Cord Blood Cells Restore Brain Damage Induced Changes in Rat Somatosensory Cortex

  2011cited by this paper
• Human Mesenchymal Stem Cells Efficiently Manage Oxidative Stress

  2010cited by this paper
• Administration of human umbilical cord blood cells produces interleukin-10 (IL-10) in IL-10 deficient mice without immunosuppression.

  2010cited by this paper
• Human Cord Blood Transplantation in a Neonatal Rat Model of Hypoxic–Ischemic Brain Damage: Functional Outcome Related to Neuroprotection in the Striatum

  2010cited by this paper
• Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors.

  2009cited by this paper
• Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death

  2009cited by this paper
• Systemic delivery of umbilical cord blood cells for stroke therapy: A review

  2009cited by this paper
• Amoeboid Microglia in the Periventricular White Matter Induce Oligodendrocyte Damage through Expression of Proinflammatory Cytokines via MAP Kinase Signaling Pathway in Hypoxic Neonatal Rats

  2008cited by this paper
• Pathogenesis of cerebral white matter injury of prematurity

  2007cited by this paper
• Maturation-Dependent Vulnerability of Perinatal White Matter in Premature Birth

  2007cited by this paper
• The effect of cerebral hypothermia on white and grey matter injury induced by severe hypoxia in preterm fetal sheep

  2007cited by this paper
• Neonatal MRI to predict neurodevelopmental outcomes in preterm infants.

  2006cited by this paper
• Can we define the pathogenesis of human periventricular white-matter injury using animal models?

  2006cited by this paper
• Spastic Paresis After Perinatal Brain Damage in Rats Is Reduced by Human Cord Blood Mononuclear Cells

  2006cited by this paper
• Increased “Vigilance” of Antioxidant Mechanisms in Neural Stem Cells Potentiates Their Capability to Resist Oxidative Stress

  2006cited by this paper
• Can We Define the Pathogenesis of Human Periventricular White-Matter Injury Using Animal Models?

  2006cited by this paper
• Fetal and neonatal origins of altered brain development.

  2005cited by this paper
• Hypoxic-Ischemic Injury Stimulates Subventricular Zone Proliferation and Neurogenesis in the Neonatal Rat

  2005cited by this paper
• Oxidative and Nitrative Injury in Periventricular Leukomalacia: A Review

  2005cited by this paper
• Central Nervous System Entry of Peripherally Injected Umbilical Cord Blood Cells Is Not Required for Neuroprotection in Stroke

  2004cited by this paper
• Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia

  2003cited by this paper
• Cerebral white matter injury of the premature infant-more common than you think.

  2003cited by this paper
• Biology of oligodendrocyte and myelin in the mammalian central nervous system.

  2001cited by this paper
• Central Role of Microglia in Neonatal Excitotoxic Lesions of the Murine Periventricular White Matter

  2001cited by this paper
• Can cord blood be used for autologous transfusion in preterm neonates?

  2000cited by this paper
• Lipid peroxidation and antioxidants in erythrocyte membranes of full term and preterm newborns

  1998cited by this paper
• A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: morphological changes indicative of apoptosis.

  1998cited by this paper
• Maternal Intrauterine Infection, Cytokines, and Brain Damage in the Preterm Newborn

  1997cited by this paper
• Cellular and molecular pathogenesis of periventricular white matter injury

  1997cited by this paper
• In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note

  1995cited by this paper
• A “radical” view of cerebral ischemic injury

  1994cited by this paper

• The effects of therapeutic drugs on brain development in infants with fetal growth restriction.

  2026cites this paper
• Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024)

  2025cites this paper
• Umbilical cord blood collection through elective cesarean section in an ovine model – a pilot study

  2025cites this paper
• Potential Applications of Umbilical Cord Blood-Derived Cells in Neonatal Diseases.

  2025cites this paper
• Transplanted oligodendrocyte progenitor cells improve neurological defects in a rat model of preterm white-matter injury during the sequela phase

  2025cites this paper
• Combined therapy of human amnion-derived mesenchymal stem cells and scalp acupuncture alleviates brain damage in a rat model of cerebral palsy

  2025cites this paper
• Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy

  2025cites this paper
• Persistent inflammation and white matter damage in the preterm brain: Insights from a novel ovine model of chronic inflammation.

  2025cites this paper
• Cord blood-derived cell therapies for preterm brain injury.

  2025cites this paper
• Highlighting the CORD‐SaFe Trial From Melbourne—Progress Toward Cellular Therapy in Extremely Preterm Newborns

  2025cites this paper
• Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol

  2025cites this paper
• The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS—A Review Focusing on Neuroprotective Properties

  2024cites this paper
• Oligodendrocyte Progenitor Cell Transplantation Reduces White Matter Injury in a Fetal Goat Model

  2024cites this paper
• Stem cell therapy in improving the motor function of patients with cerebral palsy: Systematic review with meta-analysis

  2024cites this paper
• Balance of Antioxidants vs. Oxidants in Perinatal Asphyxia

  2024cites this paper
• Umbilical cord blood derived cell expansion: a potential neuroprotective therapy

  2024cites this paper
• The Impact of Umbilical Cord Mesenchymal Stem Cells on Motor Function in Children with Cerebral Palsy: Results of a Real-world, Compassionate use Study

  2024cites this paper
• Early administration of umbilical cord blood cells following brief high tidal volume ventilation in preterm sheep: a cautionary tale

  2024influential citation
• Potential Role of Endoplasmic Reticulum Stress in Modulating Protein Homeostasis in Oligodendrocytes to Improve White Matter Injury in Preterm Infants

  2024cites this paper
• Feasibility of cord blood collection for autologous cell therapy applications in extremely preterm infants.

  2023cites this paper
• Key roles of glial cells in the encephalopathy of prematurity

  2023cites this paper
• Effects of fetal growth restriction on the perinatal neurovascular unit and possible treatment targets

  2023cites this paper
• Acquired Brain Injuries Across the Perinatal Spectrum: Pathophysiology and Emerging Therapies.

  2023cites this paper
• Factors Influencing the Efficacy of Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury

  2023cites this paper
• Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants.

  2023cites this paper
• Endothelial colony forming cell administration promotes neurovascular unit development in growth restricted and appropriately grown fetal lambs

  2023cites this paper
• Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges

  2022cites this paper
• Editorial: Perinatal hypoxic-ischemic brain injury: Mechanisms, pathogenesis, and potential therapeutic strategies

  2022cites this paper
• A Novel Murine Multi-Hit Model of Perinatal Acute Diffuse White Matter Injury Recapitulates Major Features of Human Disease

  2022cites this paper
• Umbilical cord blood-derived cell therapy for perinatal brain injury: A systematic review & meta-analysis of preclinical studies - Part B

  2022cites this paper
• Human umbilical cord blood mononuclear cells transplantation for perinatal brain injury

  2022cites this paper
• Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy

  2022cites this paper
• Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury: A Systematic Review & Meta-Analysis of Preclinical Studies

  2022influential citation
• Emerging neuroprotective interventions in periventricular leukomalacia - A systematic review of preclinical studies

  2022influential citation
• Stem cells in neonatal diseases: An overview.

  2022cites this paper
• Future perspectives on cell therapy for autism spectrum disorder

  2022cites this paper
• Preventing Brain Injury in the Preterm Infant—Current Controversies and Potential Therapies

  2021cites this paper
• Subacute AMD3100 Treatment Is Not Efficient in Neonatal Hypoxic-Ischemic Rats

  2021cites this paper
• Oligodendrocyte Development and Implication in Perinatal White Matter Injury

  2021cites this paper
• Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage

  2021cites this paper
• Umbilical cord blood therapy modulates neonatal hypoxic ischemic brain injury in both females and males

  2021cites this paper
• Preventing Brain Damage from Hypoxic–Ischemic Encephalopathy in Neonates: Update on Mesenchymal Stromal Cells and Umbilical Cord Blood Cells

  2021cites this paper
• Therapeutic potential of stem cells for preterm infant brain damage: can we move from the heterogeneity of preclinical and clinical studies to established therapeutics?

  2021cites this paper
• Umbilical cord blood CD34+ cells administration improved neurobehavioral status and alleviated brain injury in a mouse model of cerebral palsy

  2021cites this paper
• Umbilical cord blood cells for the treatment of preterm white matter injury: Potential effects and treatment options

  2020cites this paper
• Neurovascular effects of umbilical cord blood-derived stem cells in growth-restricted newborn lambs

  2020cites this paper
• Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models

  2020cites this paper
• Umbilical Cord Blood Cells Do Not Reduce Ventilation-Induced Lung Injury in Preterm Lambs

  2020cites this paper
• Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

  2020cites this paper
• Autologous transplantation of umbilical cord blood-derived cells in extreme preterm infants: protocol for a safety and feasibility study

  2020cites this paper
• Multiple doses of umbilical cord blood cells improve long-term brain injury in the neonatal rat.

  2020cites this paper
• Genetic and microstructural differences in the cortical plate of gyri and sulci during gyrification in fetal sheep.

  2020cites this paper
• Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key

  2020cites this paper
• Systemic multipotent adult progenitor cells protect the cerebellum after asphyxia in fetal sheep

  2020cites this paper
• Window of opportunity for human amnion epithelial stem cells to attenuate astrogliosis after umbilical cord occlusion in preterm fetal sheep

  2020cites this paper
• Postnatal Nutrition to Improve Brain Development in the Preterm Infant: A Systematic Review From Bench to Bedside

  2019cites this paper
• Pediatric Stroke and Cell-Based Treatment – Pivotal Role of Brain Plasticity

  2019cites this paper
• Stem Cell Therapy for Preventing Neonatal Diseases in the 21st Century: Current Understanding and Challenges

  2019cites this paper
• The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models

  2019cites this paper
• Cord blood stem cells to reduce preterm brain injury

  2019cites this paper
• Mechanism and Treatment Related to Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy

  2019cites this paper
• Human Umbilical Cord Therapy Improves Long-Term Behavioral Outcomes Following Neonatal Hypoxic Ischemic Brain Injury

  2019cites this paper
• Prevention, Reduction and Repair of Brain Injury of the Preterm Infant

  2019cites this paper
• Umbilical cord blood versus mesenchymal stem cells for inflammation-induced preterm brain injury in fetal sheep

  2019cites this paper
• Successful use of an artificial placenta to support extremely preterm ovine fetuses at the border of viability.

  2019cites this paper
• Recent advances in perinatal neuroprotection

  2019cites this paper
• Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges

  2019influential citation
• Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period

  2018cites this paper
• Effect of T helper cell 1/T helper cell 2 balance and nuclear factor-κB on white matter injury in premature neonates.

  2018cites this paper
• Chronic inflammation and impaired development of the preterm brain.

  2018cites this paper
• The risk of neurodevelopmental disorders at age 10 years associated with blood concentrations of interleukins 4 and 10 during the first postnatal month of children born extremely preterm

  2018cites this paper
• A New Approach to Cerebral Palsy Treatment: Discussion of the Effective Components of Umbilical Cord Blood and its Mechanisms of Action

  2018cites this paper
• Umbilical cord blood cells for treatment of cerebral palsy; timing and treatment options

  2018cites this paper
• Future perspectives of cell therapy for neonatal hypoxic–ischemic encephalopathy

  2018cites this paper
• EEG sharp waves are a biomarker of striatal neuronal survival after hypoxia-ischemia in preterm fetal sheep

  2018cites this paper
• Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury

  2018influential citation
• Neuropathology as a consequence of neonatal ventilation in premature growth-restricted lambs.

  2018cites this paper
• Human Umbilical Cord Blood Therapy Protects Cerebral White Matter from Systemic LPS Exposure in Preterm Fetal Sheep

  2018cites this paper
• Preterm umbilical cord blood derived mesenchymal stem/stromal cells protect preterm white matter brain development against hypoxia‐ischemia

  2018influential citation
• Embryonic intraventricular transplantation of neural stem cells augments inflammation-induced prenatal brain injury.

  2018cites this paper
• New Strategy of Clinical Studies for Premature Babies with Ischemic Brain Damage

  2018cites this paper
• The paradox of the preterm fetus

  2017cites this paper
• Umbilical Cord Blood Cells for Perinatal Brain Injury: The Right Cells at the Right Time?

  2017cites this paper
• Human Amnion Epithelial Cells Protect against White Matter Brain Injury after Repeated Endotoxin Exposure in the Preterm Ovine Fetus

  2017cites this paper
• Term vs. preterm cord blood cells for the prevention of preterm brain injury

  2017cites this paper
• Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep

  2017cites this paper
• Ischemic brain injury: New insights on the protective role of melatonin.

  2017cites this paper
• A quantitative method for microstructural analysis of myelinated axons in the injured rodent brain

  2017cites this paper
• Chapter 2 New Strategy of Clinical Studies for Premature Babies with Ischemic Brain Damage

  year unknowncites this paper